Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors help hair regrowth in kids with alopecia areata but need more safety research.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Storing hair follicles in a special buffer with certain inhibitors can increase hair growth and improve transplant results.

Hair straightening changes hair structure and can cause damage if done wrong, but improvements in the methods are expected to continue.

Changes in skin bacteria may relate to alopecia areata severity.

Certain NK cell changes in blood may indicate alopecia areata progression.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Hirudo verbana extract improves hair growth and wound healing in rats.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Using combined treatments can help manage acne by targeting the bacteria and skin changes that cause it.

Different conditions affect how hair proteins assemble, and certain mutations can change their structure.

Congenital Adrenal Hyperplasia is mainly caused by enzyme deficiencies, leading to varying symptoms like hormone imbalances and physical changes.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Improper diet, lifestyle, and stress are major causes of hair fall.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Tofacitinib is an effective and safe treatment for alopecia areata.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.